Future research priorities include clarifying the context-dependent duality of IGF-1, delineating its protective versus pathogenic roles across disease stages and cell types, and mapping crosstalk with core PAH pathways such as BMPR2/TGF-β signaling. The gene discussed is TGFB1; the disease is pulmonary arterial hypertension.